New York (1)

Metastatic Castration Sensitive Prostate Cancer (1)

Active, not recruiting (1)

phase 2 (1)

Memorial Sloan Kettering Cancer Center (1)

Ferring Pharmaceuticals (1)

degarelix (1)

ipilimumab (1)

radical prostatectomy (1)

drug (1)

procedure (1)

Other (1)

Interventional (1)

metastatic castration sensitive prostate cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Aug 4, 2022